isobavachin has been researched along with uric acid in 1 studies
| Studies (isobavachin) | Trials (isobavachin) | Recent Studies (post-2010) (isobavachin) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 12 | 0 | 8 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | isobavachin (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chen, Y; Li, L; Li, Y; Liao, H; Lin, C; Luo, J; Pang, J; Tian, J; Tian, Y; Wu, T; Yang, Y; Zhang, Q; Zhang, S; Zhao, K; Zhao, Z; Zheng, F | 1 |
1 other study(ies) available for isobavachin and uric acid
| Article | Year |
|---|---|
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
Topics: Animals; Flavones; Kidney; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2023 |